Ocudox

Product NDC
54799-535
11-digit product format
547990535
Labeler code
54799
Product ID
54799-535_3b4ab940-1578-44be-a69d-e7de1b2e9e6b
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Doxycycline Hyclate
Dosage form
CAPSULE
Route
ORAL
Labeler
OCuSOFT INC.
Application
ANDA062675
Marketing category
ANDA
Marketing start
2011-04-01
Marketing end
0000-00-00
Substance
DOXYCYCLINE HYCLATE
Active strength
50 mg/1
Pharmacologic classes
Tetracycline-class Drug [EPC],Tetracyclines [CS]
NDC exclude flag
No
Listing certified through
2020-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct54799-535DDiscontinued by firm2026-10-05
excluded packagepackage54799-53554799-535-60DDiscontinued by firm2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage54799-535-60d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage54799-535-60f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage54799-535-602ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage54799-535-60a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage54799-535-60cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage54799-535-60cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage54799-535-60302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage54799-535-60ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage54799-535-600efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage54799-535-60ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage54799-535-60367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage54799-535-60557ba5c1ecfa…9c80585c8c6e…

Source provenance: Browse the complete Orange Book source catalog.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
54799-535-60EA - Each54799-535c0268196-f620-4baa-90e2-b03836a01d3b12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
Doxycycline HyclateACTIVE INGREDIENT19XTS3T51UOCUDOX (DOXYCYCLINE HYCLATE) CAPSULE [OCUSOFT INC.]18
DOXYCYCLINE ANHYDROUSACTIVE MOIETY334895S862OCUDOX (DOXYCYCLINE HYCLATE) CAPSULE [OCUSOFT INC.]18
anhydrous lactoseINACTIVE INGREDIENT3SY5LH9PMKOCUDOX (DOXYCYCLINE HYCLATE) CAPSULE [OCUSOFT INC.]18
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UOCUDOX (DOXYCYCLINE HYCLATE) CAPSULE [OCUSOFT INC.]18
croscarmellose sodiumINACTIVE INGREDIENTM28OL1HH48OCUDOX (DOXYCYCLINE HYCLATE) CAPSULE [OCUSOFT INC.]18
D&C RED NO. 28INACTIVE INGREDIENT767IP0Y5NHOCUDOX (DOXYCYCLINE HYCLATE) CAPSULE [OCUSOFT INC.]18
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDOCUDOX (DOXYCYCLINE HYCLATE) CAPSULE [OCUSOFT INC.]18
GELATININACTIVE INGREDIENT2G86QN327LOCUDOX (DOXYCYCLINE HYCLATE) CAPSULE [OCUSOFT INC.]18
magnesium stearateINACTIVE INGREDIENT70097M6I30OCUDOX (DOXYCYCLINE HYCLATE) CAPSULE [OCUSOFT INC.]18
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPOCUDOX (DOXYCYCLINE HYCLATE) CAPSULE [OCUSOFT INC.]18